TheEdgeResearch
Home / Stocks / CMOTEC-B.ST

Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)

STO Healthcare Biotechnology
$3.67 ▲ +0.00%
Market Cap
$87.4M
Sector
Healthcare
Industry
Biotechnology
Beta
0.96
52-Wk Range
1.9-7.76
CEO
Stefan Mohan Frick
Country
SE
Currency
SEK

Scandinavian ChemoTech AB (publ) operates in the Biotechnology industry of the Healthcare sector, headquartered in Lund, SN, SE. The stock last traded at $3.67, up 0.00% on the session, giving a market capitalisation of $87.4M. Its beta of 0.96 implies it has historically moved less than the broad market.

Company profile
Exchange
Stockholm Stock Exchange
Employees
1
IPO date
2016-12-06
Headquarters
Lund, SN, SE
About Scandinavian ChemoTech AB (publ)

Scandinavian ChemoTech AB (publ), a medical technology company, engages in the radiation physics, surgical oncology, and clinical development in Sweden and internationally. It operates in two divisions, Human Care and Animal Care. The company offers IQWave, an electroporation that generates a tumour-specific electrical stimulation; and veterinary medicines under the vetIQur name. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.

Comparable companies

Scandinavian ChemoTech AB (publ) is most often compared with the following Healthcare names:

ALZNALZ.STCALCCANTA.STERMA.STGUBRA.COONCO.STPHGESLDBSNDX
More research on CMOTEC-B.ST
CMOTEC-B.ST technical analysis CMOTEC-B.ST TheEdge Score Compare against peers
Open full interactive analysis & DCF →